144 related articles for article (PubMed ID: 29688733)
1. Drug Use for Secondary Prevention of Cardiovascular Diseases in Golestan, Iran: Results From the Golestan Cohort Study.
Nalini M; Sepanlou SG; Pourshams A; Poustchi H; Sharafkhah M; Bahrami H; Kamangar F; Malekzadeh R
Arch Iran Med; 2018 Mar; 21(3):86-94. PubMed ID: 29688733
[TBL] [Abstract][Full Text] [Related]
2. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey.
Yusuf S; Islam S; Chow CK; Rangarajan S; Dagenais G; Diaz R; Gupta R; Kelishadi R; Iqbal R; Avezum A; Kruger A; Kutty R; Lanas F; Lisheng L; Wei L; Lopez-Jaramillo P; Oguz A; Rahman O; Swidan H; Yusoff K; Zatonski W; Rosengren A; Teo KK;
Lancet; 2011 Oct; 378(9798):1231-43. PubMed ID: 21872920
[TBL] [Abstract][Full Text] [Related]
3. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
Høgh AL
Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and correlates of cardiovascular medication use among nursing home residents with ischemic heart disease: results from the SHELTER study.
Foebel AD; Liperoti R; Gambassi G; Gindin J; Ben Israel J; Bernabei R; Onder G
J Am Med Dir Assoc; 2014 Jun; 15(6):410-5. PubMed ID: 24559641
[TBL] [Abstract][Full Text] [Related]
5. Drug secondary prevention in postmenopausal women with ischemic heart disease.
Zdrenghea D; Pop D; Sitar-Tăut A; Cebanu M; Zdrenghea V
Rom J Intern Med; 2009; 47(1):41-5. PubMed ID: 19886068
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular Medication Use and Long-Term Outcomes of First Nations and Non-First Nations Patients Following Diagnostic Angiography: A Retrospective Cohort Study.
Dahl L; Schultz A; McGibbon E; Brownlie J; Cook C; Elbarouni B; Katz A; Nguyen T; Sawatzky JA; Sinclaire M; Throndson K; Prior HJ; Fransoo R
J Am Heart Assoc; 2019 Aug; 8(16):e012040. PubMed ID: 31405352
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of drug therapy in the secondary prevention of cardiovascular disease and stroke.
Fletcher GF; Bufalino V; Costa F; Goldstein LB; Jones D; Smaha L; Smith SC; Stone N
Am J Cardiol; 2007 Mar; 99(6C):1E-35E. PubMed ID: 17378996
[No Abstract] [Full Text] [Related]
8. Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data.
Khatib R; McKee M; Shannon H; Chow C; Rangarajan S; Teo K; Wei L; Mony P; Mohan V; Gupta R; Kumar R; Vijayakumar K; Lear SA; Diaz R; Avezum A; Lopez-Jaramillo P; Lanas F; Yusoff K; Ismail N; Kazmi K; Rahman O; Rosengren A; Monsef N; Kelishadi R; Kruger A; Puoane T; Szuba A; Chifamba J; Temizhan A; Dagenais G; Gafni A; Yusuf S;
Lancet; 2016 Jan; 387(10013):61-9. PubMed ID: 26498706
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort.
Bai JW; Boulet G; Halpern EM; Lovblom LE; Eldelekli D; Keenan HA; Brent M; Paul N; Bril V; Cherney DZ; Weisman A; Perkins BA
Cardiovasc Diabetol; 2016 Jan; 15():14. PubMed ID: 26809442
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular disease prevention using fixed dose pharmacotherapy in Iran: updated meta-analyses and mortality estimation.
Sepanlou SG; Farzadfar F; Jafari E; Danaei G
Arch Iran Med; 2012 Sep; 15(9):531-7. PubMed ID: 22924369
[TBL] [Abstract][Full Text] [Related]
11. Medication use in long-term survivors from the MONICA/KORA Myocardial Infarction Registry.
Amann U; Kirchberger I; Heier M; Thilo C; Kuch B; Meisinger C
Eur J Intern Med; 2018 Jan; 47():62-68. PubMed ID: 28826823
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Cardiovascular Diseases Among Elderly Residents of Long-term Care Facilities.
Kańtoch A; Gryglewska B; Wójkowska-Mach J; Heczko P; Grodzicki T
J Am Med Dir Assoc; 2018 May; 19(5):428-432. PubMed ID: 29402648
[TBL] [Abstract][Full Text] [Related]
13. Re: Secondary medical prevention in patients with peripheral arterial disease.
Schouten O; Welten GM; Bax JJ; Poldermans D
Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):59-60. PubMed ID: 17719805
[No Abstract] [Full Text] [Related]
14. Survival prospects after acute myocardial infarction in the UK: a matched cohort study 1987-2011.
Gitsels LA; Kulinskaya E; Steel N
BMJ Open; 2017 Jan; 7(1):e013570. PubMed ID: 28119386
[TBL] [Abstract][Full Text] [Related]
15. Drug therapies in the secondary prevention of cardiovascular diseases: Successes, shortcomings and future directions.
Lonn E; Grewal J
Curr Vasc Pharmacol; 2006 Jul; 4(3):253-68. PubMed ID: 16842143
[TBL] [Abstract][Full Text] [Related]
16. [Factors influencing secondary prevention of atherothrombotic disease in the private outpatient cardiology setting: results of the Prisma survey].
Cambou JP; Ferrieres J; Grenier O; Boka G; Cantet C; Leizorovicz A
Ann Cardiol Angeiol (Paris); 2003 Feb; 52(1):20-9. PubMed ID: 12710291
[TBL] [Abstract][Full Text] [Related]
17. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients.
Naderi SH; Bestwick JP; Wald DS
Am J Med; 2012 Sep; 125(9):882-7.e1. PubMed ID: 22748400
[TBL] [Abstract][Full Text] [Related]
18. Use of evidence-based therapy for the prevention of cardiovascular events among older people.
Castelino RL; Chen TF; Guddattu V; Bajorek BV
Eval Health Prof; 2010 Sep; 33(3):276-301. PubMed ID: 20801973
[TBL] [Abstract][Full Text] [Related]
19. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.
Halvorsen S; Jortveit J; Hasvold P; Thuresson M; Øie E
BMC Cardiovasc Disord; 2016 May; 16():115. PubMed ID: 27246583
[TBL] [Abstract][Full Text] [Related]
20. [Impact of different intervention models on adherence to secondary prevention therapies in patients with acute coronary syndrome].
Liu J; Wang W; Liu J; Wang Y; Qi Y; Sun JY; Zhao D
Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Feb; 46(2):124-130. PubMed ID: 29495236
[No Abstract] [Full Text] [Related]
[Next] [New Search]
